Empowered Funds LLC Invests $1.89 Million in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Empowered Funds LLC bought a new position in Ryan Specialty Holdings, Inc. (NYSE:RYAN – Get Rating) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 46,429 shares of the company’s stock, valued at approximately $1,886,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Venture Visionary Partners LLC purchased a new stake in shares of Ryan Specialty in the second quarter worth about $27,000. Royal Bank of Canada lifted its stake in shares of Ryan Specialty by 524.8% in the first quarter. Royal Bank of Canada now owns 781 shares of the company’s stock worth $31,000 after acquiring an additional 656 shares in the last quarter. First Horizon Advisors Inc. acquired a new position in shares of Ryan Specialty in the second quarter worth about $42,000. American International Group Inc. acquired a new position in shares of Ryan Specialty in the second quarter worth about $50,000. Finally, Quantbot Technologies LP acquired a new position in shares of Ryan Specialty in the second quarter worth about $51,000. Hedge funds and other institutional investors own 26.82% of the company’s stock.

Ryan Specialty Stock Down 0.8 %

Shares of Ryan Specialty stock opened at $41.86 on Wednesday. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 2.58. The business’s 50 day simple moving average is $40.65 and its 200-day simple moving average is $41.67. The stock has a market capitalization of $10.87 billion, a price-to-earnings ratio of 91.00 and a beta of 0.50. Ryan Specialty Holdings, Inc. has a twelve month low of $32.13 and a twelve month high of $46.40.

Ryan Specialty (NYSE:RYAN – Get Rating) last announced its quarterly earnings results on Thursday, November 10th. The company reported $0.25 earnings per share for the quarter, missing analysts’ consensus estimates of $0.28 by ($0.03). The company had revenue of $412.00 million for the quarter, compared to analyst estimates of $422.46 million. Ryan Specialty had a return on equity of 47.01% and a net margin of 8.81%. Equities research analysts forecast that Ryan Specialty Holdings, Inc. will post 1.14 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Citigroup assumed coverage on Ryan Specialty in a research note on Wednesday, December 14th. They issued a “neutral” rating and a $42.00 price target on the stock. BMO Capital Markets began coverage on Ryan Specialty in a research note on Thursday, January 19th. They issued an “outperform” rating and a $51.00 price target on the stock. Wells Fargo & Company upped their price objective on Ryan Specialty from $45.00 to $47.00 and gave the company an “overweight” rating in a research note on Wednesday, January 18th. JPMorgan Chase & Co. cut their price objective on Ryan Specialty from $40.00 to $39.00 in a research note on Friday, November 11th. Finally, UBS Group cut their price objective on Ryan Specialty to $48.00 in a research note on Wednesday, November 16th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $46.13.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, Director Michael D. Ohalleran acquired 11,750 shares of the firm’s stock in a transaction that occurred on Tuesday, November 15th. The stock was acquired at an average cost of $33.71 per share, with a total value of $396,092.50. Following the acquisition, the director now directly owns 564,228 shares of the company’s stock, valued at approximately $19,020,125.88. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. In other Ryan Specialty news, Director Michael D. Ohalleran acquired 11,750 shares of the firm’s stock in a transaction that occurred on Tuesday, November 15th. The stock was acquired at an average cost of $33.71 per share, with a total value of $396,092.50. Following the acquisition, the director now directly owns 564,228 shares of the company’s stock, valued at approximately $19,020,125.88. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Patrick G. Ryan acquired 288,038 shares of the firm’s stock in a transaction that occurred on Monday, November 21st. The stock was acquired at an average cost of $38.26 per share, with a total value of $11,020,333.88. Following the completion of the acquisition, the chief executive officer now directly owns 6,129,340 shares in the company, valued at $234,508,548.40. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 1,044,848 shares of company stock worth $39,211,853. 54.30% of the stock is currently owned by company insiders.

Ryan Specialty Company Profile

(Get Rating)

Ryan Specialty Group Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.